We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current MIRM market cap is 2.05B. The company's latest EPS is USD -3.4042 and P/E is -12.53.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 31.6M | 37.5M | 47.73M | 69.55M | 90.38M |
| Operating Income | -27.15M | -24.27M | -25.15M | -32.59M | -12.68M |
| Net Income | -30.13M | -74.04M | -23.59M | -35.66M | -14.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 19.14M | 77.06M | 186.37M |
| Operating Income | -54.74M | -104.3M | -173.41M | -131.22M | -109.15M |
| Net Income | -52.55M | -103.27M | -83.99M | -135.67M | -163.42M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 333.53M | 443.59M | 650.64M | 646.62M | 667.89M |
| Total Liabilities | 192.38M | 364.98M | 381.56M | 397.95M | 435.87M |
| Total Equity | 141.15M | 78.61M | 269.08M | 248.67M | 232.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 146.71M | 240.86M | 294.65M | 352.91M | 646.62M |
| Total Liabilities | 16.36M | 68.77M | 174.44M | 210.87M | 397.95M |
| Total Equity | 130.35M | 172.1M | 120.21M | 142.04M | 248.67M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -33.77M | -36.11M | -54.33M | -70.94M | 15.39M |
| Investing | 42.02M | 77.56M | -105.2M | -107.2M | -90.77M |
| Financing | 12.99M | 127.69M | 334.82M | 336.6M | 12.36M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.36M | -89.08M | -132.76M | -120.14M | -70.94M |
| Investing | -127.78M | 37.87M | 48.55M | 7.7M | -107.2M |
| Financing | 127.18M | 181.29M | 73.47M | 109.09M | 336.6M |
| Market Cap | 2.05B |
| Price to Earnings Ratio | -12.53 |
| Price to Sales Ratio | 10.99 |
| Price to Cash Ratio | 7.15 |
| Price to Book Ratio | 8.23 |
| Dividend Yield | - |
| Shares Outstanding | 48M |
| Average Volume (1 week) | 385.39k |
| Average Volume (1 Month) | 359.85k |
| 52 Week Change | 55.83% |
| 52 Week High | 48.89 |
| 52 Week Low | 23.14 |
| Spread (Intraday) | 12.76 (24.17%) |
| Company Name | Mirum Pharmaceuticals Inc |
| Address |
838 walker road dover, delaware 19904 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
